medline.ch Gastroenterologie Pankreas Neoplasie

	Response to: "Re: 'Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study'". Cir Esp (Engl Ed) Manchon-Walsh P, Sánchez-Velázquez P, Espín-Álvarez F, Guarga L. PMID: 42918326 [PubMed - as supplied by publisher]
	Re: "Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: A modified Delphi study". Cir Esp (Engl Ed) Barzola E, Padillo J. PMID: 42918325 [PubMed - as supplied by publisher]
	Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group. Lancet Oncol Oar A, Kneebone A, Sjoquist KM, Espinoza D, Lee M, Le H, Gholamrezaei L, Chu J, Lynam J, Mallesara G, Lee D, Vignarajah D, Ward I, Samra J, Barbour A, Whitehead A, Brooks S, Nicholson A, Wang TW, Ng W, Ali F, Siu D, Gaitan JL, Cook O, Moore A, Oostendorp MB, Yip S, Shakeshaft J, Pryor D, Nguyen N, Goldstein D, Australasian Gastro-Intestinal Trials Group (AGITG). PMID: 42914998 [PubMed - as supplied by publisher]
	Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Radiother Oncol Liermann J, Naumann P, Jäkel C, Baumann L, Koczur B, Röhrich M, Englert FH, Jessen I, Tawk B, Knoll M, Baltazar F, Harrabi S, Springfeld C, Michalski C, Haberkorn U, Mairani A, Abdollahi A, Kieser M, Debus J, Herfarth K. PMID: 42913944 [PubMed - as supplied by publisher]
	Is it possible to predict resectability in pancreatic cancers? A retrospective study in a tertiary center. Cir Cir Ceylan C, Cengiz E, Kayaalp C, Aydin C. PMID: 42913615 [PubMed - indexed for MEDLINE]
	Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E). Future Oncol Sano Y, Maruki Y, Morizane C, Nomura S, Fukuda H, Ikeda M, Ozaka M, Kobayashi S, Ohkawa K, Mizuno N, Tsumura H, Fujimori N, Komatsu Y, Takata N, Yasuda I, Nakachi K, Otsuru T, Honda T, Okusaka T, Ueno M, Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. PMID: 42911120 [PubMed - as supplied by publisher]
	Metabolic Barriers to Cancer Immunotherapy: Multiscale Mechanisms from Organelle Dysfunction to Organ-Specific Constraints. Int J Biol Sci Gui Z, Yuan X, Chen X, Huang Q, Zhang B, Liang J. PMID: 42910256 [PubMed - indexed for MEDLINE]
	Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience. BMC Cancer Trinkl L, Thöne P, Dierneder J, Rumpold H. PMID: 42907811 [PubMed - indexed for MEDLINE]
	Pancreatic head solid-pseudopapillary neoplasm in a man treated by robot-assisted laparoscopic partial pancreatectomy: a case report. BMC Surg Ma R, Liu W, Yang Y, Tian X. PMID: 42907798 [PubMed - indexed for MEDLINE]
	Metabolomics and Biomarker Discovery. Adv Exp Med Biol Sinclair K, Dudley E. PMID: 42907622 [PubMed - indexed for MEDLINE]
	Natural polysaccharides in pancreatic cancer therapy: From immunomodulation and gut microbiota regulation to metabolic intervention. Carbohydr Polym Lu D, Du R, Yang K, Guo L, Kuang H, Wang Z. PMID: 42907040 [PubMed - indexed for MEDLINE]
	Survival impact of involvement of lymph node stations 16b1, 9, and 8a during pancreatoduodenectomy for pancreatic and periampullary cancers (PANODE): prospective multicentre study. BJS Open Suurmeijer JA, Pranger BK, Seelen LWF, Ali M, van Rijssen LB, Tseng DS, Mackay TM, van Dam JL, van Santvoort HC, Groot Koerkamp B, Sarasqueta AF, van Eijck CH, Liem MSL, Kazemier G, Nieuwenhuijs VB, de Hingh IH, Klaase JM, Erdmann JI, Busch OR, Molenaar IQ, de Meijer VE, Besselink MG, Dutch Pancreatic Cancer Group. PMID: 42905970 [PubMed - indexed for MEDLINE]
	A prospective cohort study of dietary intake and clinical-nutritional biomarkers in patients with periampullary malignancies undergoing pancreatoduodenectomy in Southeast Brazil. Support Care Cancer Ribeiro MA, Dos Santos JS, da Silva Castro Perdoná G, Navarro AM. PMID: 42905299 [PubMed - indexed for MEDLINE]
	Amphicrine Carcinomas of the Pancreas Showing Neuroendocrine and Acinar Cell Differentiation: A Case Report and Literature Review. Pathol Int Huang Y, Hu H, Zheng C, Lv K, Jiang H, He T. PMID: 42904842 [PubMed - indexed for MEDLINE]
	From CAF subtypes to clinically relevant states: cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Front Immunol Hao Y, Wang Y, Du Q, Li G. PMID: 42903681 [PubMed - indexed for MEDLINE]
	[Digestive neuroendocrine tumors : the importance of a multidisciplinary approach]. Rev Med Suisse Marx M, Schaefer N, Cruchon K, Sykiotis G, Jreige M, Sempoux C, La Rosa S, Serra F, Dalex M, Godat S, Duran R, Melloul E, Diciolla A, Wagner AD, Dottrens U, Ho J, Teixeira Farinha V, Dromain C. PMID: 42902975 [PubMed - indexed for MEDLINE]
	Next-Generation CAR-Macrophage Therapies: Design Principles and Advances in Cancer Treatment. Cancer Lett Wang W, Guo S, Chu Q, Yu Q, Romero M, Shi X, Shan S, Gao C, Fu S, Ren H. PMID: 42901433 [PubMed - as supplied by publisher]
	Dynamic Expression Quantitative Trait Locus Mendelian Randomization in Activated CD4-Positive T Cells Nominates SMDT1 and CMTM7 as Candidate Genes in Pancreatic Cancer. Mol Carcinog Wang H, Wang B, Duan X, Jiao G, Chen M, Guan X, Cao J, Cui L, Li H, Li Z. PMID: 42900762 [PubMed - as supplied by publisher]
	Dual-channel digital surface-enhanced Raman spectroscopy resolves GPC1(+)MUC4(+) single-exosome heterogeneity released by PANC-1 and BxPC-3 pancreatic cancer cells. Anal Methods Wang X, Zhang Z, Zheng B. PMID: 42900490 [PubMed - as supplied by publisher]
	Construction of a liver hepatocellular carcinoma risk model based on fumarate metabolism-associated genes to predict prognosis and immunological landscape. Clin Exp Med Chen S, Xie S, Mei Y, Yu H, Yan J. PMID: 42900287 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 61940

Seite 1 von 3097

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung